
Page#1
Table of Contents
BED BATH & BEYOND INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(in thousands, except per share data)
February 29, March 2, 
 2020  2019
Assets 
Current assets: 
Cash and cash equivalents $ 1,000,340  $ 508,971
Short term investment securities 385,642  485,799
Merchandise inventories 2,093,869  2,618,922
Prepaid expenses and other current assets 248,342  296,280
Assets held-for-sale 98,092  —
Total current assets 3,826,285  3,909,972
Long term investment securities 20,380  20,010
Property and equipment, net 1,430,604  1,853,091
Operating lease assets 2,006,966  —
Goodwill —  391,052
Other assets 506,280  396,416
Total assets $ 7,790,515  $ 6,570,541
Liabilities and Shareholders' Equity 
Current liabilities: 
Accounts payable $ 944,194  $ 1,094,078
Accrued expenses and other current liabilities 675,776  623,734
Merchandise credit and gift card liabilities 340,407  339,322
 Current operating lease liabilities 463,005  —
 Liabilities related to assets held-for-sale 43,144  —
 Current income taxes payable —  20,498
Total current liabilities 2,466,526  2,077,632
Other liabilities 204,926  395,409
Operating lease liabilities 1,818,783  —
Income taxes payable 46,945  49,235
Long term debt 1,488,400  1,487,934
 
Total liabilities 6,025,580  4,010,210
 
Shareholders' equity: 
Preferred stock - $0.01 par value; authorized - 1,000 shares; no shares issued or outstanding —  —
Common stock - $0.01 par value; authorized - 900,000 shares; issued 343,683 and 342,582, respectively;
outstanding 126,528 and 132,233 shares, respectively 3,436  3,426
Additional paid-in capital 2,167,337  2,118,673
Retained earnings 10,374,826  11,112,887
Treasury stock, at cost (10,715,755)  (10,616,045)
Accumulated other comprehensive loss (64,909)  (58,610)
Total shareholders' equity 1,764,935  2,560,331
Total liabilities and shareholders' equity $ 7,790,515  $ 6,570,541
See accompanying Notes to Consolidated Financial Statements.
33
Page#2
Table of Contents
BED BATH & BEYOND INC. AND SUBSIDIARIES
Consolidated Statements of Operations
(in thousands, except per share data)
 Twelve Months Ended
February 29,
 2020  March 2, 2019  March 3, 2018
Net sales $ 11,158,580  $ 12,028,797  $ 12,349,301
 
Cost of sales 7,616,920  7,924,817  7,906,286
 
Gross profit 3,541,660  4,103,980  4,443,015
 
Selling, general and administrative expenses 3,732,498  3,681,210  3,681,694
 
Goodwill and other impairments 509,226  509,905  —
 
Operating (loss) profit (700,064)  (87,135)  761,321
 
Interest expense, net 64,789  69,474  65,661
 
(Loss) earnings before provision for income taxes (764,853)  (156,609)  695,660
 
(Benefit) provision for income taxes (151,037)  (19,385)  270,802
 
Net (loss) earnings $ (613,816)  $ (137,224)  $ 424,858
 
Net (loss) earnings per share - Basic $ (4.94)  $ (1.02)  $ 3.05
Net (loss) earnings per share - Diluted $ (4.94)  $ (1.02)  $ 3.04
 
Weighted average shares outstanding - Basic 124,352  134,292  139,238
Weighted average shares outstanding - Diluted 124,352  134,292  139,739
 
Dividends declared per share $ 0.68  $ 0.64  $ 0.60
See accompanying Notes to Consolidated Financial Statements.
34
Page#3
Table of Contents
BED BATH & BEYOND INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(in thousands)
 Twelve Months Ended
February 29,
 2020  March 2, 2019  March 3, 2018
Cash Flows from Operating Activities: 
Net (loss) earnings $ (613,816)  $ (137,224)  $ 424,858
Adjustments to reconcile net (loss) earnings to net cash provided by operating activities: 
Depreciation and amortization 342,511  338,825  313,107
Loss on sale leaseback transaction 27,357  —  —
Gain on sale of building —  (29,690)  —
Gain on debt extinguishment —  (412)  —
Goodwill and other impairments 509,226  509,905  —
Stock-based compensation 45,676  58,514  70,510
Deferred income taxes (145,543)  (104,089)  175,351
Other (3,446)  (814)  (69)
Decrease (increase) in assets, net of effect of acquisitions: 
Merchandise inventories 506,334  106,928  176,672
Trading investment securities 21  86,277  (16,036)
Other current assets (4,781)  269,186  (258,853)
Other assets 218  218  (4,754)
(Decrease) increase in liabilities, net of effect of acquisitions: 
Accounts payable (124,206)  (90,657)  13,210
Accrued expenses and other current liabilities 61,864  (77,147)  80,375
Merchandise credit and gift card liabilities 1,154  16,016  25,510
Income taxes payable (22,783)  8,360  (64,941)
Operating lease assets and liabilities, net (2,899)  —  —
Other liabilities 14,054  (35,918)  (75,251)
Net cash provided by operating activities 590,941  918,278  859,689
Cash Flows from Investing Activities: 
Purchase of held-to-maturity investment securities (443,500)  (734,424)  (292,500)
Redemption of held-to-maturity investment securities 545,000  538,925  —
Capital expenditures (277,401)  (325,366)  (375,793)
Proceeds from sale-leaseback transaction 267,277  —  —
Proceeds from sale of a building —  11,183  —
Payment for acquisitions, net of cash acquired —  —  (6,119)
Net cash provided by (used in) investing activities 91,376  (509,682)  (674,412)
Cash Flows from Financing Activities: 
Payment of dividends (85,482)  (86,287)  (80,877)
Repurchase of common stock, including fees (99,710)  (148,073)  (252,433)
Payment of senior notes —  (4,224)  —
Proceeds from exercise of stock options 2,346  —  10,313
Payment of other liabilities —  —  (434)
Net cash used in financing activities (182,846)  (238,584)  (323,431)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (977)  (7,181)  (4,035)
Net increase (decrease) in cash, cash equivalents and restricted cash, including cash balances
classified as assets held-for-sale 498,494  162,831  (142,189)
  Less: Cash balances classified as assets held-for sale (4,815)  —  —
Net increase (decrease) in cash, cash equivalents and restricted cash 493,679  162,831  (142,189)
Cash, cash equivalents and restricted cash: 
Beginning of period 529,971  367,140  509,329
End of period $ 1,023,650  $ 529,971  $ 367,140
See accompanying Notes to Consolidated Financial Statements.